Hepatic uptake of propranolol

Area of Science:

• Pharmacology
• Hepatology
• Drug Metabolism

Background:

• Propranolol is a beta-blocker with significant hepatic extraction.
• Understanding its liver uptake mechanisms is crucial for predicting drug efficacy and toxicity.
• Previous studies suggest complex hepatic handling of propranolol.

Purpose of the Study:

• To elucidate the biphasic uptake kinetics of propranolol in isolated rat livers.
• To differentiate between physical binding and metabolic processes in hepatic propranolol uptake.
• To investigate the influence of temperature, oxygen, and other drugs on propranolol uptake.

Main Methods:

• Isolated rat liver perfusion in a simplified recirculation system.
• Monitoring propranolol concentration decline over time.
• Autoradiography to visualize tissue distribution.
• Investigating effects of temperature, oxygen, and co-administered drugs.

Main Results:

• Biphasic propranolol decline observed: rapid initial uptake followed by slower elimination.
• Rapid phase was flow-limited, temperature/oxygen-independent, suggesting physical binding.
• Autoradiography revealed high propranolol concentration in periportal zones.
• Slow phase was metabolism-dependent, influenced by temperature, oxygen, and other drugs.
• Some drugs inhibited the slow phase and could displace propranolol.

Conclusions:

• Rat liver propranolol uptake is a biphasic process involving initial rapid physical binding and subsequent slower metabolism.
• Physical binding, primarily in periportal areas, is distinct from metabolic clearance.
• These findings provide insights into hepatic drug disposition and potential drug-drug interactions.